Inventor · disambiguated record
Paul Truex
Also filed as: TRUEX PAUL · TRUEX PAUL F
1 granted patent·5 pending applications·2 citations·filing 2004–2011
21Inventor score
Top patents by PatentIndex Score
6 records- 0166US8048880B2Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase A2 (SPLA2) inhibitors and SPLA2 inhibitor combination therapiesANTHERA PHARMACEUTICALS INC·Filed 2008·Granted Nov 1, 2011·2 cites·30 claims
- 0244US2005065141A1Carbapenems useful in treating and preventing pulmonary infections, pharmaceutical compositions thereof and modes of administration thereofFiled 2004·Application pending·0 cites
- 0339US2010160361A1Treatment of major adverse cardiac events and acute coronary syndrome using secretory phospholipase a2 (spla2) inhibitor or spla2 inhibitor combination therapiesHISLOP COLIN·Filed 2009·Application pending·0 cites
- 0435US2008299585A1METHODS FOR DETECTION AND MEASUREMENT OF SECRETORY PHOSPHOLIPASE A2 LEVELS (sPLA2) IN BIOLOGICAL FLUIDSTRUEX PAUL·Filed 2007·Application pending·0 cites
- 0531US2011269786A1Treatment of major adverse cardiac events and acute coronary syndrome in diabetic patients using secretory phospholipase a2 (spla2) inhibitor or spla2 inhibitor combination therapiesHISLOP COLIN·Filed 2011·Application pending·0 cites
- 0629US2011207710A1Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase a2 (spla2) inhibitors and spla2 inhibitor combination therapiesTRIAS JOAQUIM·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →